InsidersTradesSigma
Follow the HLB제약 stock price and the full management transaction log of the company, a listed issuer based in South Korea. Shares are quoted on the KR market, under the authority of DART (FSS). Operating in the Health Care sector, HLB제약 has recorded 8 reports. Market capitalisation: €271.6bn. The latest transaction was reported on 26 August 2026 (Purchase). Among the most active insiders: HLB생명과학. The full history is accessible without an account.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
HLB제약 is a company in the health and pharmaceutical sector, listed on the XKRX market. It focuses on the development of innovative drugs and therapeutic solutions.